U.S. Markets closed

Agile Therapeutics, Inc. (AGRX)


NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
3.84-0.07 (-1.79%)
At close: 4:00PM EDT
People also watch
ALDXADHDADMSAFMDFLXN
Full screen
Previous Close3.91
Open3.88
Bid0.00 x
Ask0.00 x
Day's Range3.83 - 4.05
52 Week Range1.82 - 8.15
Volume1,454,044
Avg. Volume217,984
Market Cap110.62M
Beta1.80
PE Ratio (TTM)-3.82
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks Small Cap Researchlast month

    AGRX: Initiating Coverage of Agile Therapeutics; NDA for Weekly Contraceptive Patch Set to Be Filed…

    We are initiating coverage of Agile Therapeutics, Inc. (AGRX) with a $7.00 valuation. The company’s lead product, Twirla® (AG200-15), is a once-weekly low-dose combination hormonal contraceptive patch. Agile has conducted a comprehensive development program for Twirla® that includes three Phase 3 clinical trials, and the company will be resubmitting the new drug application (NDA) during the first half of 2017.

  • Associated Press2 months ago

    Agile Therapeutics reports 1Q loss

    On a per-share basis, the Princeton, New Jersey-based company said it had a loss of 26 cents. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

  • Agile Therapeutics (AGRX) Catches Eye: Stock Moves Up 14%
    Zacks3 months ago

    Agile Therapeutics (AGRX) Catches Eye: Stock Moves Up 14%

    Agile Therapeutics, Inc. (AGRX) moved big last session, as its shares rose almost 14% on the day.